1. Home
  2. VMI vs ARWR Comparison

VMI vs ARWR Comparison

Compare VMI & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valmont Industries Inc.

VMI

Valmont Industries Inc.

HOLD

Current Price

$541.50

Market Cap

9.8B

Sector

Industrials

ML Signal

HOLD

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$72.41

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VMI
ARWR
Founded
1946
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
10.2B
IPO Year
1994
2009

Fundamental Metrics

Financial Performance
Metric
VMI
ARWR
Price
$541.50
$72.41
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$500.33
$83.40
AVG Volume (30 Days)
209.7K
2.0M
Earning Date
04-21-2026
05-07-2026
Dividend Yield
0.63%
N/A
EPS Growth
N/A
99.80
EPS
5.51
N/A
Revenue
$3,169,556,000.00
$16,142,321.00
Revenue This Year
$5.53
N/A
Revenue Next Year
$5.59
N/A
P/E Ratio
$98.23
N/A
Revenue Growth
14.52
N/A
52 Week Low
$326.22
$14.30
52 Week High
$585.71
$87.83

Technical Indicators

Market Signals
Indicator
VMI
ARWR
Relative Strength Index (RSI) 48.42 37.28
Support Level $391.12 $70.05
Resistance Level $548.90 $74.60
Average True Range (ATR) 15.10 4.17
MACD -4.92 -1.22
Stochastic Oscillator 24.89 0.25

Price Performance

Historical Comparison
VMI
ARWR

About VMI Valmont Industries Inc.

Valmont Industries Inc, along with its subsidiaries, operates as a manufacturer of products and services for infrastructure and agriculture markets. Its reportable segments are Infrastructure and Agriculture. The company generates maximum revenue from the Infrastructure segment, which includes the manufacturing and distribution of products and solutions to serve the infrastructure markets of utility, solar, lighting, transportation, and telecommunications, along with coatings services to protect metal products. The Agriculture segment provides irrigation equipment components, including aftermarket parts and tubular products, and technology solutions for precision agriculture. Geographically, it derives key revenue from the United States, followed by Australia, Brazil, and other regions.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Share on Social Networks: